|
業務類別
|
Biotechnology |
|
業務概覽
|
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom. |
| 公司地址
| 601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131 |
| 電話號碼
| +1 305 203-2034 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.smmttx.com |
| 員工數量
| 265 |
| Dr. Mahkam Zanganeh |
Executive Director,Co-Chief Executive Officer and President |
-- |
08/08/2024 |
| Mr. Robert W. Duggan |
Executive Director,Chairman and Chief Executive Officer |
-- |
08/08/2024 |
|
|
| Dr. Yu Xia |
Non-Executive Director |
08/08/2024 |
| Mr. Kenneth A. Clark |
Non-Executive Director,Lead Independent Director |
08/08/2024 |
| Dr. Alessandra Cesano, M.D. |
Non-Executive Director |
08/08/2024 |
| Ms. Ujwala Mahatme |
Non-Executive Director |
08/08/2024 |
| Mr. Manmeet Singh Soni |
Non-Executive Director |
08/08/2024 |
| Dr. Mahkam Zanganeh |
Executive Director,Co-Chief Executive Officer and President |
08/08/2024 |
| Mr. Robert W. Duggan |
Executive Director,Chairman and Chief Executive Officer |
08/08/2024 |
| Mr. Robert Booth |
Non-Executive Director |
08/08/2024 |
|
|
|
|
